$46.08 +0.31 (%) Abbott Laboratories - NYSE

Dec. 19, 2014 | 12:55 PM

Partner Headlines

  1. #PreMarket Primer: Friday, December 19: U.S. Debates A Response To Sony Hackers

    Benzinga | Dec. 19, 2014 | 08:17AM EST
  2. Analysts See No Sweeter Deal For Volcano

    Benzinga | Dec. 17, 2014 | 15:34PM EST
  3. Philips Buying Volcano To Boost Image-Guided Therapy

    IBD | Dec. 17, 2014 | 11:34AM EST
  4. US Stock Futures Tumble Ahead Of Producer Prices, Consumer Sentiment Data

    Benzinga | Dec. 12, 2014 | 06:52AM EST
  5. Diamond Hill Adds Two Companies to Portfolio in Third Quarter

    GuruFocus | Dec. 11, 2014 | 15:19PM EST
  6. Boston Scientific Lost the First Place in Innovation

    GuruFocus | Dec. 11, 2014 | 14:41PM EST
  7. Top 7 Dividend Aristocrats: The Best of The Best

    GuruFocus | Dec. 10, 2014 | 15:05PM EST
  8. Top 4 NYSE Stocks In The Drugs-Generic Industry With The Highest Profit Margin

    Benzinga | Dec. 9, 2014 | 05:09AM EST
  9. 6 Stocks Giving Investors Potential Dividend Hikes In December

    GuruFocus | Dec. 4, 2014 | 13:05PM EST
  10. Fast Money Picks For December 3: Canadian Pacific, Abbott Labs, BlackBerry And Ford

    Benzinga | Dec. 3, 2014 | 07:47AM EST
  11. Jon Najarian Sees Unusual Options Activity In Abbott Laboratories

    Benzinga | Dec. 3, 2014 | 07:31AM EST
  12. Dividend Aristocrats In Focus Part 45: AbbVie

    GuruFocus | Nov. 24, 2014 | 16:13PM EST
  13. Zoetis 2015 Guidance Misses As Buyout Theories Abound

    IBD | Nov. 18, 2014 | 15:15PM EST
  14. Vipshop Leads 4 Top Stocks With Bolting RS Lines

    IBD | Nov. 18, 2014 | 08:02AM EST
  15. Five Ethical Drugmakers Keep Leadership Positions

    IBD | Nov. 17, 2014 | 18:27PM EST
  16. Benzinga's M&A Chatter for Monday November 17, 2014

    Benzinga | Nov. 17, 2014 | 18:11PM EST
  17. Mylan Rises On Q3 Earnings Beat, Affirms Abbott Deal

    IBD | Oct. 31, 2014 | 11:17AM EST
  18. Top 4 NYSE Stocks In The Medical Appliances & Equipment Industry With The Highest Dividend Yield

    Benzinga | Oct. 31, 2014 | 04:59AM EST
  19. Benzinga's M&A Chatter for Wednesday October 29, 2014

    Benzinga | Oct. 29, 2014 | 20:53PM EST
  20. Benzinga's Top Upgrades

    Benzinga | Oct. 29, 2014 | 09:47AM EST
  21. Deutsche Bank Upgrades Abbott Laboratories To Buy

    Benzinga | Oct. 29, 2014 | 08:34AM EST
  22. Deutsche Bank Upgrades Abbott Laboratories

    Benzinga | Oct. 29, 2014 | 08:33AM EST
  23. Amgen Q3 Earnings Beat Estimates; Guidance Mixed

    IBD | Oct. 27, 2014 | 18:56PM EST
  24. Better Biotechs Don't Satisfy

    IBD | Oct. 22, 2014 | 18:53PM EST
  25. Abbott Laboratories Conference Call Highlights

    Benzinga | Oct. 22, 2014 | 16:59PM EST
  26. Biogen, Thermo Reports Disappoint; Abbott Accelerates

    IBD | Oct. 22, 2014 | 11:18AM EST
  27. UPDATE: Abbott Q3 Earnings Top Street View

    Benzinga | Oct. 22, 2014 | 09:21AM EST
  28. Earnings Scheduled For October 22, 2014

    Benzinga | Oct. 22, 2014 | 05:16AM EST
  29. Keep an Eye on These 7 Stocks, October 22nd, 2014

    Benzinga | Oct. 22, 2014 | 04:04AM EST
  30. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga | Oct. 19, 2014 | 10:19AM EST
  31. Making Money With Charles Payne: 10/17/14

    FoxBusiness | Oct. 17, 2014 | 18:00PM EST
  32. AbbVie Rethinking Shire Deal

    IBD | Oct. 15, 2014 | 18:40PM EST
  33. Shire Falls, AbbVie Questioned On Buyout Backtrack

    IBD | Oct. 15, 2014 | 13:11PM EST
  34. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD | Oct. 10, 2014 | 17:37PM EST
  35. Screening For Aggressive Buyback Companies

    YCharts | Oct. 8, 2014 | 17:54PM EST
  36. Becton Buyout Of CareFusion Drives Up Both Stocks

    IBD | Oct. 6, 2014 | 11:47AM EST
  37. Jazz Pharmaceuticals Uses New Cash To Buy For Growth

    IBD | Oct. 3, 2014 | 14:39PM EST
  38. Sure Bets: Slow-Changing Industries for Long-Term Investors

    GuruFocus | Oct. 1, 2014 | 18:48PM EST
  39. Market Indicators That Could Spell Trouble for Investors

    GuruFocus | Sep. 29, 2014 | 18:56PM EST
  40. Medical Technology Company Offers Investment Opportunity

    GuruFocus | Sep. 25, 2014 | 16:00PM EST
  41. Inversion Crackdown Leaves Several Deals In Limbo

    Benzinga | Sep. 23, 2014 | 12:41PM EST
  42. Top 4 NYSE Stocks In The Medical Appliances & Equipment Industry With The Highest Revenue

    Benzinga | Sep. 11, 2014 | 04:17AM EST
  43. Abbott: A Brighter Future

    GuruFocus | Aug. 28, 2014 | 14:13PM EST
  44. Buyback Mania Inflates 2Q Earnings Growth

    FoxBusiness | Aug. 14, 2014 | 08:17AM EST
  45. 5 Companies That Have Moved Overseas For Lower Taxes

    Benzinga | Aug. 12, 2014 | 10:06AM EST
  46. 5 Family-Friendly Employers For Working Parents

    Benzinga | Jul. 31, 2014 | 14:10PM EST
  47. 30 Stocks Delisted So Far In 2014

    Benzinga | Jul. 29, 2014 | 16:31PM EST
  48. How Obama Could End Walgreen's Tax-Inversion Hopes

    IBD | Jul. 28, 2014 | 14:41PM EST
  49. Will Congress Scuttle the AbbVie-Shire Merger?

    FoxBusiness | Jul. 18, 2014 | 13:23PM EST
  50. Markets Sell-Off After Malaysian Airline Crash In Ukraine

    Benzinga | Jul. 17, 2014 | 16:50PM EST
Trading Center